max万博体育

前瞻性声明

本材料包含基于安进目前的期望和信念的前瞻性陈述。除了历史事实的陈述外，所有的陈述都可被视为前瞻性陈述，包括对未来价格、疾病影响和成本的估计以及其他此类估计和结果的估计。前瞻性陈述涉及重大风险和不确定性,包括下面讨论,更充分地描述了美国证券交易委员会(sec)提交的报告安进,包括我们的最新年度报告形式10 - 10 - k和任何后续定期报告形式和当前报告形式公布。除非另有说明，安进在本材料发布之日提供此信息，并且不承担因新信息、未来事件或其他原因而更新本文件中任何前瞻性陈述的任何义务。

没有前瞻性的陈述是可以保证的，实际的结果可能与我们的计划有实质性的不同。我们的研究结果可能会影响到我们成功的能力在国内与国际市场两个新的和现有的产品临床和监管的发展涉及到当前和未来的产品,销售增长最近推出的产品,其他产品包括生物仿制药的竞争,困难或延迟制造我们的产品和全球经济状况。此外,销售我们的产品受到价格压力的影响,政治和公众监督和报销政策由第三方支付者,包括政府、私人保险计划和管理保健提供者和可能受到监管的影响,临床和准则的发展和国内外趋势管理式医疗和医疗成本控制。此外，我们的研究、测试、定价、营销和其他业务都受到国内外政府监管部门的广泛监管。在我们的产品(包括我们的设备)上市后，我们或其他人可以确认其安全性、副作用或生产问题。我们的业务可能受到政府调查、诉讼和产品责任索赔的影响。此外，我们的业务可能会因新税法的采纳或承担额外的税务责任而受到影响。如果我们未能履行安进与美国政府之间的企业诚信协议中的合规义务，我们可能会受到重大制裁。虽然我们经常为我们的产品和技术取得专利，但我们的专利和专利申请所提供的保护可能会被我们的竞争对手挑战、失效或规避，或者我们可能无法在现在和将来的知识产权诉讼中获胜。我们在一些关键的工厂(包括波多黎各)进行大量的商业制造活动，我们的部分制造活动也依赖于第三方，供应限制可能会限制某些现有产品和候选产品的销售。 We rely on collaborations with third parties for the development of some of our product candidates and for the commercialization and sales of some of our commercial products. In addition, we compete with other companies with respect to many of our marketed products as well as for the discovery and development of new products. Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of new indications for existing products will be successful and become a commercial product. Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers. Certain of our distributors, customers and payers have substantial purchasing leverage in their dealings with us. The discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations. Our efforts to acquire other companies or products and to integrate the operations of companies we have acquired may not be successful. A breakdown, cyberattack or information security breach could compromise the confidentiality, integrity and availability of our systems and our data. Our stock price is volatile and may be affected by a number of events. Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock. We may not be able to access the capital and credit markets on terms that are favorable to us, or at all.